Nitrosigine is a patented ingredient, inositol-stabilized arginine silicate, developed specifically to overcome the bioavailability limitations of standard L-Arginine. Standard oral arginine is largely broken down before it reaches circulation in meaningful amounts, which is why studies on plain L-Arginine show inconsistent results. Nitrosigine's bonded structure protects arginine through digestion and significantly increases the amount that enters the bloodstream where it can stimulate nitric oxide production. NutraLife uses Nitrosigine at 1,500mg per can, the dose used in clinical research, not a reduced amount.

Nitrosigine has been shown to begin increasing nitric oxide levels within 30 minutes of a single serving. This is not a slow-build ingredient that requires days or weeks of loading. One can of NutraLife delivers 1,500mg of Nitrosigine, and the blood flow effect begins in under half an hour. Benefits have been documented to persist for up to 6 hours post-consumption, making NutraLife an effective daily performance tool even outside of structured training windows.

The 31% figure comes from published clinical research on Nitrosigine at the 1,500mg dose measuring blood flow to working muscle. It reflects a real, documented physiological outcome, increased vessel dilation driven by elevated nitric oxide levels. In practical terms, improved blood flow means oxygen and nutrients reach working muscle faster, and metabolic waste clears more efficiently. NutraLife uses this stat because it is sourced directly from peer-reviewed research on this exact ingredient at this exact dose.

Nitrosigine and L-Citrulline work through different mechanisms in the nitric oxide production pathway. Nitrosigine provides a direct nitric oxide precursor via the arginine conversion route. L-Citrulline works upstream in the urea cycle, converting to arginine in the kidneys and feeding the nitric oxide pathway from a separate entry point. Using both at full clinical doses creates a dual nitric oxide system where each ingredient amplifies the other's effect. This combination produces a greater combined output than either ingredient alone, and it is one of the meaningful differences between NutraLife and functional beverages that rely on a single nitric oxide ingredient.

1,500mg is the dose used in the clinical research on Nitrosigine. The 50+ human trials that document its blood flow, endurance, and cognitive effects are conducted at this dose. Lower doses have not been studied with the same consistency. NutraLife uses 1,500mg because that is the amount the research supports, and because the dose is disclosed on the label so you can verify it yourself.

Yes. Nitrosigine works through a physiological mechanism, nitric oxide production, rather than a stimulant mechanism. It does not require cycling, does not build tolerance in the way stimulant compounds do, and does not produce a crash. The research on Nitrosigine includes sustained daily use protocols. NutraLife is specifically formulated for daily performance use. The caffeine-free version of NutraLife contains no stimulants at all, making it appropriate for any time of day.

Nitrosigine was developed to solve a specific problem with standard L-Arginine -- poor oral bioavailability. Most L-Arginine is broken down before it reaches the bloodstream, which is why studies on plain L-Arginine show inconsistent results. L-Citrulline converts to arginine in the kidneys and feeds the nitric oxide pathway from upstream, and it is genuinely effective at clinical doses. NutraLife uses Nitrosigine at 1,500mg and L-Citrulline at 1,000mg together, a dual nitric oxide system that addresses the pathway from two different angles.